Rubella Vaccine
12 brands · 8 companies · product forms
Opportunity snapshot
12
brands
8
companies
0
price points
0x
price spread
65
confidence %
Who competes here
Top companies by brand count · leader share 25%
3 brands · 25%
2 brands · 17%
2 brands · 17%
1 brands · 8%
1 brands · 8%
1 brands · 8%
1 brands · 8%
1 brands · 8%
Why this score
Launch attractiveness
40% supply-gap(0) + 25% price-variation(0) + 20% low-competition(79) + 15% supply-disruption(0), damped by confidence(65). Higher = more attractive, less crowded opportunity.
Market saturation
8 canonical companies and 12 brands compete (saturation pegged at 30 companies / 150 brands).
Price room
Only 0 trusted price points; variation not scored (low data).
Regulatory risk
No DRAP alerts on this molecule's brands.
Confidence
Reduced by: sparse price data, no ATC code.
Packaged brief for this lower opportunity?
Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.
See packaged reports All 3868 molecules